Skip to main content
Ir a la página de inicio de la Comisión Europea (se abrirá en una nueva ventana)
español es
CORDIS - Resultados de investigaciones de la UE
CORDIS

Innovative risk assessment for individualizing treatment in chronic lymphocytic leukemia

Objetivo

Chronic lymphocytic leukemia faces high-challenging and timely problems related to the classification and efficient prognosis of patients at the time of diagnosis and the attempt to personalize the treatment. CLLassify addresses these issues in a pioneering fashion within a multidisciplinary collaboration, proposing an improved classification of the patients, based on innovative statistical techniques as well as the novel aspect of personalized prediction of the need for treatment at a specific time point for the individual patient. The statistical background of the applicant, together with the expertise of his supervisor in CLL, guarantee the successful implementation of this project. This will result both in significant health advances and societal benefits for the European society at large raising the project at the level of a European priority, and to significant improvement of the applicant’s career prospects within Europe.

Ámbito científico (EuroSciVoc)

Programa(s)

Tema(s)

Régimen de financiación

MSCA-IF-EF-ST - Standard EF

Ver todos los proyectos financiados en el marco de este régimen de financiación

Convocatoria de propuestas

(se abrirá en una nueva ventana) H2020-MSCA-IF-2015

Ver todos los proyectos financiados en el marco de esta convocatoria

Coordinador

ETHNIKO KENTRO EREVNAS KAI TECHNOLOGIKIS ANAPTYXIS
Aportación neta de la UEn
€ 164 653,20
Dirección
CHARILAOU THERMI ROAD 6 KM
570 01 THERMI THESSALONIKI
Grecia
Región
Βόρεια Ελλάδα Κεντρική Μακεδονία Θεσσαλονίκη
Tipo de actividad
Research Organisations
Enlaces
Coste total
€ 164 653,20